Home > Insider Trading > Filing (0001209191-22-038116)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1652724	Lucira Health Inc.	LHDX	In Vitro & In Vivo Diagnostic Substances (2835)	272491037

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1839384	T. Erik Engelson	1412 62Nd Street Emeryville CA 94608	President And Chief Executive	Yes	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2022-06-16	10,000	$1.49	63,282	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	46,400	Indirect	See footnote
Common Stock	191,705	Indirect	See footnote

Footnotes

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.45 to $1.50, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
The shares are held by the Elisabeth North Kuechler Engelson Trust, dated January 17, 2001, for which Mr. Engelson serves as trustee.
The shares are held by Epic Pacific, LLC, of which Mr. Engelson is a Member. Mr. Engelson disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein.